This is not the most recent version of the article. View current version (12 DEC 2012)

Methodology Protocol

Industry sponsorship and research outcome

  1. Andreas Lundh1,*,
  2. Joel Lexchin2,
  3. Sergio Sismondo3,
  4. Octavian A Busuioc3,
  5. Lisa Bero4

Editorial Group: Cochrane Methodology Review Group

Published Online: 7 SEP 2011

DOI: 10.1002/14651858.MR000033


How to Cite

Lundh A, Lexchin J, Sismondo S, Busuioc OA, Bero L. Industry sponsorship and research outcome (Protocol). Cochrane Database of Systematic Reviews 2011, Issue 9. Art. No.: MR000033. DOI: 10.1002/14651858.MR000033.

Author Information

  1. 1

    Rigshospitalet, The Nordic Cochrane Centre, Copenhagen, Denmark

  2. 2

    York University, School of Health Policy and Management, Toronto, Ontario, Canada

  3. 3

    Queen's University, Department of Philosophy, Kingston, Ontario, Canada

  4. 4

    University of California San Francisco, Department of Clinical Pharmacy, San Francisco, California, USA

*Andreas Lundh, The Nordic Cochrane Centre, Rigshospitalet, 3343, Blegdamsvej 9, Copenhagen, DK-2100, Denmark. al@cochrane.dk.

Publication History

  1. Publication Status: New
  2. Published Online: 7 SEP 2011

SEARCH

This is not the most recent version of the article. View current version (12 DEC 2012)

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

The objectives are to investigate whether:

  • funding of drug studies by the pharmaceutical industry is associated with outcomes that are favorable to the funder;
  • drug studies funded by the pharmaceutical industry differ in their risk of bias compared with studies with other sources of support;
  • funding of device studies by the device industry is associated with outcomes that are favorable to the funder; and
  • device studies funded by the device industry differ in their risk of bias compared with studies with other sources of support.